Cisatracurium

Trade name

Cisatracurium (Accord), Cisatracurium (AFT), Cisatracurium (Juno), Cisatracurium (Kalcex), DBL Cisatracurium, Nimbex

Strength

2 mg/mL (volume: 2.5 mL, 5 mL, 10 mL, 25 mL)

5 mg/mL (volume: 30 mL)

IV administration

Give undiluted by rapid injection over 5 to 10 seconds.

For continuous infusion, give undiluted or dilute to 0.1 to 2 mg/mL.

RCH Standard Concentrations: 100 mg/50 mL (2 mg/mL)

Other routes of administration

IM: Not recommended.

SC: Not recommended.

Compatible IV fluids

Glucose 5%

Sodium chloride 0.9%

Cisatracurium 0.1 mg/mL or weaker:

Glucose 5% and sodium chloride 0.9% 

Y-site only and cisatracurium in glucose 5%:

Potassium chloride 20 mmol/L

Additional information

Extravasation risk.

For use in theatre or intensive care settings only.

Refrigerate, do not freeze.

Solution should be colourless to pale yellow or greenish yellow.

Discard any unused vial contents.

Protect from light during storage.